- Home
- ENOV
ENOV
Enovis Corporation
as 05-31-2024 4:00pm EST
Enovis Corp is a medical technology company focused on developing clinically differentiated solutions that generate measurable patient outcomes and transform workflows by manufacturing and distributing high-quality medical devices with a broad use for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company conducts its operations through two operating segments: Prevention & Recovery (P&R) and Reconstructive (Recon). It generates the majority of revenue from the Prevention & Recovery segment.
| Founded: | 1995 | Country: | United States |
| Employees: | N/A | City: | WILMINGTON |
| Market Cap: | 2.8B | IPO Year: | 2008 |
| Target Price: | $74.88 | AVG Volume (30 days): | 486.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.49 | EPS Growth: | N/A |
| 52 Week Low/High: | $43.04 - $66.14 | Next Earning Date: | 05-02-2024 |
| Revenue: | $1,817,312,000 | Revenue Growth: | 14.02% |
| Revenue Growth (this year): | 26.87% | Revenue Growth (next year): | 7.43% |
Latest Enovis Corporation News
ENOV Breaking Stock News: Dive into ENOV Ticker-Specific Updates for Smart Investing
Zacks
4 days ago
Zacks Industry Outlook Highlights Hims & Hers Health, Enovis Corp and Health Catalyst
Zacks
5 days ago
3 Medical Info Systems Stocks to Buy as GenAI Transforms Healthcare
Argus Research
13 days ago
Analyst Report: Enovis Corp
Argus Research
13 days ago
Market Digest: AIG, AMAT, CPRT, IFF, MDU, OSK, BCE, VTR, ENOV
GuruFocus.com
18 days ago
Alan Fournier's Strategic Moves in Q1 2024 Highlighted by Major Stake in Enovis Corp
Zacks
23 days ago
5 Medical Info Systems Stocks to Buy for Stable Returns
GlobeNewswire
23 days ago
Enovis to Participate in Upcoming Investor Conferences
Zacks
a month ago
Here's Why Enovis (ENOV) is Poised for a Turnaround After Losing -17.45% in 4 Weeks
Share on Social Networks:
Disclaimer
The information presented on this page, "ENOV Enovis Corporation - Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.